6 Min Read

In this article:

• What are the functions of neurotrophins in neuronal development?
• How is neurotrophin signaling implicated in depression and neurodegeneration?
• What research tools can be used to study neurotrophin pathways?

 

Introduction: The Function of Neurotrophins in Neuronal Development

Neurotrophins are a family of secreted proteins that are critical for the development and maintenance of the nervous system. Their primary role during development is to regulate neuronal populations by promoting the survival of neurons that form appropriate connections and inducing programmed cell death (apoptosis) in those that do not. This process is essential for establishing correct innervation densities. For instance, in some parts of the vertebrate nervous system, over 50% of the initially generated neurons are eliminated through this mechanism. In the adult nervous system, neurotrophins mediate synaptic plasticity, which is fundamental for learning and memory.

Proteins:

1. Recombinant Human/Mouse BDNF Proteins – Test direct effects on neuronal cultures to study synaptic plasticity and cell survival pathways.

The figure shows the main intracellular signaling pathways and the different effects on the cell. 
("Figure from 'Neurotrophin Signaling Impairment by Viral Infections in the Central Nervous System' by Bohmwald, K, et al., published in International Journal of Molecular Sciences, 2022, licensed under CC BY 4.0. The original figure can be found at https://www.mdpi.com/1422-0067/23/10/5817)

 

Core Neurotrophins and Their Receptors

The classical neurotrophin family consists of structurally related proteins that signal through the Tropomyosin receptor kinase (Trk) family of receptor tyrosine kinases.

1. Nerve Growth Factor (NGF): The first neurotrophin to be discovered, NGF is essential for the survival and maintenance of sensory and sympathetic neurons and signals primarily through the TrkA receptor.
2. Brain-Derived Neurotrophic Factor (BDNF): BDNF is highly expressed in the central nervous system, particularly the hippocampus, and is a key mediator of synaptic plasticity, learning, and mood regulation. It signals through the TrkB receptor.
3. Neurotrophin-3 (NT-3): NT-3 has a broader range of action, signaling through the TrkC receptor but also activating TrkA and TrkB. It is involved in the development of proprioceptive neurons.

Beyond these, other growth factors like Fibroblast Growth Factor (FGF) and Ciliary Neurotrophic Factor (CNTF) also exhibit neurotrophic activities. We offer a complete panel of recombinant neurotrophins and highly specific antibodies for TrkA, TrkB, TrkC, including those that detect phosphorylation events (e.g., Anti-phospho-TrkB) to dissect these pathways.

 

Role in Health, Disease, and Therapeutics

Depression

Chronic stress is a major risk factor for depression and has been shown to decrease the expression of BDNF mRNA in the hippocampus. Conversely, a wide range of antidepressant treatments, from SSRIs to electroconvulsive therapy, robustly increases BDNF expression, suggesting this is a key mechanism of their therapeutic action.

Elisa Kits:

1. Stress-Induction‎ & ‎ Corticosterone Assay Kits – Model chronic stress in vitro and in vivo to study its impact on neurotrophin expression.
2. BDNF ELISA Kits – Quantify changes in neurotrophin levels in response to stress or treatment paradigms.

Neurodegenerative Disease

A loss of trophic support is a feature of diseases like Alzheimer's and Parkinson's. For example, evidence points to altered BDNF signaling in the progression of Alzheimer's disease. This has led to research into neurotrophin-based therapies. However, the clinical application of neurotrophin proteins is severely limited by their poor pharmacokinetic profiles (e.g., short half-life) and inability to cross the blood-brain barrier effectively.

1. Alzheimer's Disease is a brain disorder that causes progressive memory loss and cognitive decline. It's defined by the toxic build-up of amyloid-beta protein into plaques between nerve cells and tau protein into tangles inside them, leading to widespread neuron death.
2. Parkinson's Disease is a movement disorder that causes tremors, stiffness, and difficulty with balance. It results from the death of brain cells that produce dopamine, a key chemical for controlling movement, and is associated with clumps of alpha-synuclein protein called Lewy bodies.
3. Huntington's Disease is an inherited genetic disorder causing uncontrolled movements (chorea) and cognitive decline. It is caused by a mutation in the Huntingtin (Htt) gene, which creates an abnormal protein that forms toxic clumps, leading to the death of neurons, particularly in the brain's movement-control centers.

Nerve Injury and Repair

To assess nerve repair, researchers analyze key protein markers. They visualize neuronal structure with Beta III Tubulin, identify active axon regrowth with the growth cone marker GAP43, detect inhibitory glial scars using GFAP, and confirm functional recovery by staining for Myelin Basic Protein (MBP).The growth of new axonal or dendritic processes is also supported by Neurite Promoting Factors (NPFs) found in the extracellular matrix, such as Laminin and Fibronectin .

Antibodies for Visualization & Analysis:

1. Anti-Beta III Tubulin Antibody – A gold-standard marker for identifying neurons and their axons, allowing for clear visualization of neuronal morphology and regeneration.
2. Anti-GAP43 Antibody – A specific marker for neuronal growth cones, the active, seeking tip of a regenerating axon. Staining for GAP43 highlights where active regrowth is occurring.
3. Anti-GFAP Antibody – A marker for reactive astrocytes. It is used to visualize the formation of the "glial scar," a major barrier to axon regeneration in the central nervous system (CNS).
4. Anti-MBP Antibody – Targets Myelin Basic Protein, allowing for visualization of myelination by Schwann cells (in the peripheral nervous system) or oligodendrocytes (in the CNS) around regenerated axons.

 

References

1. Oppenheim, R. W. (1991). Cell death during development of the nervous system. Annual Review of Neuroscience, 14(1), 453-501.
2. Burek, M. J., & Oppenheim, R. W. (1996). Programmed cell death in the developing nervous system. Brain Pathology, 6(4), 427-446.
3. Poo, M. M. (2001). Neurotrophins as synaptic modulators. Nature Reviews Neuroscience, 2(1), 24-32.
4. Huang, E. J., & Reichardt, L. F. (2001). Neurotrophins: roles in neuronal development and function. Annual Review of Neuroscience, 24(1), 677-736.
5. Duman, R. S., & Monteggia, L. M. (2006). A neurotrophic model for stress-related mood disorders. Biological Psychiatry, 59(12), 1116-1127.
6. Unsicker, K. and Strelau, J. (2000), Functions of transforming growth factor-β isoforms in the nervous system. European Journal of Biochemistry, 267: 6972-6975. https://doi.org/10.1046/j.1432-1327.2000.01824.x.
7. Nibuya, M., Morinobu, S., & Duman, R. S. (1995). Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. Journal of Neuroscience, 15(11), 7539-7547.
8. Phillips, H. S., Hains, J. M., Armanini, M., Laramee, G. R., Johnson, S. A., & Winslow, J. W. (1991). BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron, 7(5), 695-702.
9. Thorne, R. G., & Frey, W. H. (2001). Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations. Clinical Pharmacokinetics, 40(12), 907-946.
10. Mamounas, L. A., Blue, M. E., Siuciak, J. A., & Altar, C. A. (1995). Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. Journal of Neuroscience, 15(12), 7929-7939.
11. Luckenbill-Edds, L. (1997). Laminin and the mechanism of neuronal outgrowth. Brain Research Reviews, 23(1-2), 1-27.

 

Related Pages

August 2025